Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.
about
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
P2860
Q33600072-37E7E385-CBCF-45FB-9B1C-8B32AF0DF60BQ34567456-776BA744-55CD-4263-B1B6-33E02CC18AAEQ35227792-29A19DE0-4395-4F48-8868-07BF5A5E28CEQ35599745-EA91C8FF-6669-422F-BA39-73B8DCF5E5B0Q38245797-6C4026C8-ADDC-4587-ACE4-184F549F3E3FQ45073135-BBD2A0F5-D29F-4CA7-9178-52C28430FA2BQ48293335-281D2262-859F-4559-B421-0024AB47FAEBQ54963093-FC7A672D-2D1D-4AF4-B933-6AB30FB2E216
P2860
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Anthracycline rechallenge usin ...... from four prospective trials.
@ast
Anthracycline rechallenge usin ...... from four prospective trials.
@en
type
label
Anthracycline rechallenge usin ...... from four prospective trials.
@ast
Anthracycline rechallenge usin ...... from four prospective trials.
@en
prefLabel
Anthracycline rechallenge usin ...... from four prospective trials.
@ast
Anthracycline rechallenge usin ...... from four prospective trials.
@en
P2093
P2860
P356
P1476
Anthracycline rechallenge usin ...... from four prospective trials.
@en
P2093
S Stopatschinskaja
S-E Al-Batran
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605961
P407
P577
2010-10-26T00:00:00Z
P5875
P6179
1039697584